Notification of change in shelf-life for Bovipen^® (ACVM No. A007186) and Ovipen^® (ACVM No. A007187)

Monday, 9th December 2024

Dear Customer,

We are writing to inform you of an important update regarding Bovipen and Ovipen.

As part of our commitment to maintaining the highest standards of quality and compliance, we regularly review the stability and safety profile of our products. Following a recent assessment and in adherence to regulatory requirements, the shelf-life of Bovipen and Ovipen will be reduced to 12 months. 

This change ensures that Bovipen and Ovipen continue to meet the stringent quality and efficacy standards expected from our products. The revised shelf-life will be effective for all batches manufactured from September 2024 onward. The change is effective immediately.

We would like to emphasise that this change does not affect the product's quality, safety, or effectiveness when used within the revised shelf-life period. Products already in the market with the current shelf-life remain safe for use as long as they are stored under recommended conditions and used before the reduced expiry date. If the specific expiry date assigned to a batch is stated as August 2027, this translates to the reduced shelf life as August 2025. 

If you have any questions, please contact your veterinarian, or Virbac Customer Service on 0800 847 222.

We appreciate your cooperation and continued trust in our products as we work to ensure the highest standards of quality and safety.

Yours sincerely,

Annelize Coetzee
Quality Manager
Virbac New Zealand Limited

Restricted Veterinary Medicines. Available only under a veterinary authorisation.  Registered pursuant to the ACVM Act 1997, Nos. A007186 and A007187.